Literature DB >> 16771813

BK virus infection in transplant recipients: an overview and update.

P Randhawa1, D C Brennan.   

Abstract

BK virus infection after kidney transplantation has been a subject of great interest in the past decade. This article traces the discovery of BK virus and the subsequent development of our knowledge about this emerging pathogen. The pathobiology of the virus is summarized with particular reference to epidemiology, interactions with host cell receptors, cell entry, cytoplasmic trafficking and targeting of the viral genome to the nucleus. This is followed by a discussion of clinical features, laboratory monitoring and therapeutic strategies. Finally, we present potential cellular mechanisms that explain the basis of virus-mediated damage to the human kidney.

Entities:  

Mesh:

Year:  2006        PMID: 16771813     DOI: 10.1111/j.1600-6143.2006.01403.x

Source DB:  PubMed          Journal:  Am J Transplant        ISSN: 1600-6135            Impact factor:   8.086


  38 in total

1.  Inhibitory interactions between BK and JC virus among kidney transplant recipients.

Authors:  Xingxing S Cheng; Daniel L Bohl; Gregory A Storch; Caroline Ryschkewitsch; Monique Gaudreault-Keener; Eugene O Major; Parmjeet Randhawa; Karen L Hardinger; Daniel C Brennan
Journal:  J Am Soc Nephrol       Date:  2011-04-21       Impact factor: 10.121

Review 2.  Polyomavirus-associated nephropathy.

Authors:  Cristina Costa; Rossana Cavallo
Journal:  World J Transplant       Date:  2012-12-24

3.  BK Virus-Associated Nephropathy in Kidney Transplant Recipients.

Authors:  Jorge C Garces
Journal:  Ochsner J       Date:  2010

4.  Treatment of BK viremia after renal transplantation: are fluoroquinolones a false dawn?

Authors:  Siddiq Anwar; Daniel C Brennan
Journal:  Clin J Am Soc Nephrol       Date:  2014-01-30       Impact factor: 8.237

5.  Pharmacokinetics of low-dose cidofovir in kidney transplant recipients with BK virus infection.

Authors:  J D Momper; Y Zhao; R Shapiro; K S Schonder; Y Gao; P S Randhawa; R Venkataramanan
Journal:  Transpl Infect Dis       Date:  2012-10-02       Impact factor: 2.228

6.  Antirejection treatment in kidney transplant patients with BK viruria.

Authors:  Liise K Kayler; Ibrahim Batal; Ravi Mohanka; Claire Morgan; Amit Basu; Ron Shapiro; Parmjeet S Randhawa
Journal:  Transplantation       Date:  2008-09-27       Impact factor: 4.939

7.  [Oscillation between BK virus nephropathy and rejection--the frustrating course of a living donor transplantation].

Authors:  Christine Materne; Jens Gerth; Undine Ott; Hermann-Josef Gröne; Gunter Wolf
Journal:  Med Klin (Munich)       Date:  2009-08-23

8.  Repression of BK virus infection of human renal proximal tubular epithelial cells by pravastatin.

Authors:  Takahito Moriyama; Andrey Sorokin
Journal:  Transplantation       Date:  2008-05-15       Impact factor: 4.939

9.  High frequency and diversity of rearrangements in polyomavirus bk noncoding regulatory regions cloned from urine and plasma of Israeli renal transplant patients and evidence for a new genetic subtype.

Authors:  Tsachi Tsadok Perets; Ilana Silberstein; Jana Rubinov; Ronit Sarid; Ella Mendelson; Lester M Shulman
Journal:  J Clin Microbiol       Date:  2009-03-04       Impact factor: 5.948

10.  An SV40 VP1-derived epitope recognized by CD8+ T cells is naturally processed and presented by HLA-A*0201 and cross-reactive with human polyomavirus determinants.

Authors:  Hephzibah Rani S Tagaram; Alan M Watson; Francois A Lemonnier; Kevin Staveley-O'Carroll; Satvir S Tevethia; Todd D Schell
Journal:  Virology       Date:  2008-04-10       Impact factor: 3.616

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.